MedTech News
.................... by Andrew Celentano
Whole organ 3D imaging reveals remaining insulin producing cells in type 1 diabetes
Researchers at Umeå University have conducted a unique three-dimensional mapping of an entire human pancreas. The study shows that insulin-producing cells can remain long after the onset of type 1 diabetes—a finding that suggests the disease progression is more complex than previously assumed.
FDA Grants Breakthrough Device Designation to TOBY Urine-Based Test for Alzheimer’s Disease
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the TOBY Alzheimer’s Test, a urine-based diagnostic test developed by TOBY, a biotechnology company based in Austin, Texas.
CSR secures certifications in EU and Singapore for Sentire system
The CE certification confirms compliance with regulatory standards for safety, efficacy, and quality management.
Neurovalens earns FDA nod for neuromod for PTSD
Neurovalens announced today that it received FDA de novo approval for Modius Spero, a post-traumatic stress disorder (PTSD) therapy.
AI-guided drug search flags folic acid for diabetic wound healing
Researchers from the National University of Singapore (NUS) have developed an AI-guided workflow that combines artificial intelligence (AI) with molecular simulations to identify potential drug candidates for diabetic wound healing, identifying folic acid, a common vitamin, as a top candidate.
An ‘intelligent tattoo’ to detect skin cancer before it appears
Detecting melanoma before it becomes visible is a major challenge in dermatology. Now, with researchers from Université de Montréal, scientists at Université du Québec’s Institut national de la recherche scientifique (INRS) have developed a promising solution.
Cornerstone Robotics wins CE mark for Sentire endoscopic surgical robot
Cornerstone Robotics announced today that it received CE mark approval for its Sentire endoscopic surgical robotic platform.
DNA repair protein gene gone rogue may unlock new cancer treatments
In a study published in Nature Communications, the researchers found that the EXO1 gene is overexpressed in 20% to 30% of breast and ovarian cancers as well as in melanoma, testicular, cervical, and hepatobiliary cancers, which develop in the liver, gall bladder, and bile duct